MedKoo Cat#: 596543 | Name: Levcycloserine
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Blocks sphingosine biosynthesis by inhibition of ketosphinganine synthetase. Cytotoxicity toward neuroblastoma and medulloblastoma cells mediated by suppression of ganglioside synthesis.[1] L-cycloserine is a potent inhibitor of serine palmitoyltransferase, the first step of sphingolipid synthesis.

Chemical Structure

Levcycloserine
Levcycloserine
CAS#339-72-0

Theoretical Analysis

MedKoo Cat#: 596543

Name: Levcycloserine

CAS#: 339-72-0

Chemical Formula: C3H6N2O2

Exact Mass: 102.0429

Molecular Weight: 102.09

Elemental Analysis: C, 35.29; H, 5.92; N, 27.44; O, 31.34

Price and Availability

Size Price Availability Quantity
250mg USD 285.00 2 Weeks
1g USD 650.00 2 Weeks
5g USD 1,250.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Levcycloserine; Cyclo-L-serine; Levcicloserina; L-Oxamicina; BRN 0080799;
IUPAC/Chemical Name
(S)-4-aminoisoxazolidin-3-one
InChi Key
DYDCUQKUCUHJBH-REOHCLBHSA-N
InChi Code
InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m0/s1
SMILES Code
O=C1NOC[C@@H]1N
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
L-Cycloserine ((S)-4-Amino-3-isoxazolidone) irreversibly inhibits GABA pyridoxal 5′-phosphate-dependent aminitransferase in E.
In vitro activity:
These results show a time- and concentration-dependent inactivation of MtIlvE by both isomers, with l-cycloserine being a 40-fold better inhibitor of the enzyme. Minimum inhibitory concentration (MIC) studies revealed that l-cycloserine is a 10-fold better inhibitor of Mycobacterium tuberculosis growth than d-cycloserine. Reference: ACS Chem Biol. 2017 May 19;12(5):1235-1244. https://pubmed.ncbi.nlm.nih.gov/28272868/
In vivo activity:
Studies on the effect of long term L-cycloserine treatment on sphingolipid synthesis were performed to determine whether mice could tolerate continued cerebroside reduction and whether or not the synthesis of other sphingolipids would be inhibited. L-cycloserine, when injected at a low dose for a period of two months resulted in significantly reduced brain cerebroside level with little or no reduction in sulfatide, ganglioside, or sphingomyelin levels; liver and spleen glucocerebroside levels were also significantly reduced. The rate of cerebroside synthesis in brain was greatly reduced, whereas synthesis of sulfatides was much less affected by L-cycloserine indicating that a portion of newly synthesized galactocerebroside is shunted to synthesis of sulfatides. Reference: Neurochem Res. 1989 Mar;14(3):245-8. https://pubmed.ncbi.nlm.nih.gov/2725825/
Solvent mg/mL mM
Solubility
DMSO 7.2 70.20
PBS (pH 7.2) 10.0 97.95
Water 16.7 163.23
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 102.09 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Amorim Franco TM, Favrot L, Vergnolle O, Blanchard JS. Mechanism-Based Inhibition of the Mycobacterium tuberculosis Branched-Chain Aminotransferase by d- and l-Cycloserine. ACS Chem Biol. 2017 May 19;12(5):1235-1244. doi: 10.1021/acschembio.7b00142. Epub 2017 Mar 16. PMID: 28272868; PMCID: PMC5834943. 2. Sundaram KS, Lev M. Comparative inhibition of bacterial and microsomal 3-ketodihydrosphingosine synthetases by L-cycloserine and other inhibitors. Antimicrob Agents Chemother. 1984 Aug;26(2):211-3. doi: 10.1128/AAC.26.2.211. PMID: 6486763; PMCID: PMC284122. 3. Sundaram KS, Lev M. The long-term administration of L-cycloserine to mice: specific reduction of cerebroside level. Neurochem Res. 1989 Mar;14(3):245-8. doi: 10.1007/BF00971318. PMID: 2725825. 4. Williams RD, Sgoutas DS, Zaatari GS, Santoianni RA. Inhibition of serine palmitoyltransferase activity in rabbit aorta by L-cycloserine. J Lipid Res. 1987 Dec;28(12):1478-81. PMID: 3430071.
In vitro protocol:
1. Amorim Franco TM, Favrot L, Vergnolle O, Blanchard JS. Mechanism-Based Inhibition of the Mycobacterium tuberculosis Branched-Chain Aminotransferase by d- and l-Cycloserine. ACS Chem Biol. 2017 May 19;12(5):1235-1244. doi: 10.1021/acschembio.7b00142. Epub 2017 Mar 16. PMID: 28272868; PMCID: PMC5834943. 2. Sundaram KS, Lev M. Comparative inhibition of bacterial and microsomal 3-ketodihydrosphingosine synthetases by L-cycloserine and other inhibitors. Antimicrob Agents Chemother. 1984 Aug;26(2):211-3. doi: 10.1128/AAC.26.2.211. PMID: 6486763; PMCID: PMC284122.
In vivo protocol:
1. Sundaram KS, Lev M. The long-term administration of L-cycloserine to mice: specific reduction of cerebroside level. Neurochem Res. 1989 Mar;14(3):245-8. doi: 10.1007/BF00971318. PMID: 2725825. 2. Williams RD, Sgoutas DS, Zaatari GS, Santoianni RA. Inhibition of serine palmitoyltransferase activity in rabbit aorta by L-cycloserine. J Lipid Res. 1987 Dec;28(12):1478-81. PMID: 3430071.
1: Dharmasena M, Jiang X. Improving culture media for the isolation of Clostridium difficile from compost. Anaerobe. 2018 Mar 6;51:1-7. doi: 10.1016/j.anaerobe.2018.03.002. [Epub ahead of print] PubMed PMID: 29518533. 2: Pickering DS, Vernon JJ, Freeman J, Wilcox MH, Chilton CH. Investigating the effect of supplementation on Clostridioides (Clostridium) difficile spore recovery in two solid agars. Anaerobe. 2018 Apr;50:38-43. doi: 10.1016/j.anaerobe.2018.01.010. Epub 2018 Feb 1. PubMed PMID: 29408598. 3: Zhang W, Wan S, Chen L, Wang X, Wang Z, Huang Y. Determination of cycloserine in microdialysis samples using liquid chromatography-tandem mass spectrometry with benzoyl chloride derivatization. Biomed Chromatogr. 2018 Jan 4. doi: 10.1002/bmc.4187. [Epub ahead of print] PubMed PMID: 29314157. 4: Gifford JL, Nguyen WNT, de Koning L, Seiden-Long I. Stabilizing specimens for routine ammonia testing in the clinical laboratory. Clin Chim Acta. 2018 Mar;478:37-43. doi: 10.1016/j.cca.2017.12.022. Epub 2017 Dec 16. PubMed PMID: 29258744. 5: Rezazadeh Zarandi E, Mansouri S, Nakhaee N, Sarafzadeh F, Iranmanesh Z, Moradi M. Frequency of antibiotic associated diarrhea caused by Clostridium difficile among hospitalized patients in intensive care unit, Kerman, Iran. Gastroenterol Hepatol Bed Bench. 2017 Summer;10(3):229-234. PubMed PMID: 29118940; PubMed Central PMCID: PMC5660274. 6: Ding NZ, Qi QR, Gu XW, Zuo RJ, Liu J, Yang ZM. De novo synthesis of sphingolipids is essential for decidualization in mice. Theriogenology. 2018 Jan 15;106:227-236. doi: 10.1016/j.theriogenology.2017.09.036. Epub 2017 Oct 9. PubMed PMID: 29096270. 7: Scheiblich H, Schlütter A, Golenbock DT, Latz E, Martinez-Martinez P, Heneka MT. Activation of the NLRP3 inflammasome in microglia: the role of ceramide. J Neurochem. 2017 Dec;143(5):534-550. doi: 10.1111/jnc.14225. Epub 2017 Oct 26. PubMed PMID: 28940479. 8: Howells FM, Kingdon DG, Baldwin DS. Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review. Hum Psychopharmacol. 2017 Sep;32(5). doi: 10.1002/hup.2628. Epub 2017 Aug 15. Review. PubMed PMID: 28812313. 9: Ji LY, Xu DL, Yin SP, Liu HC, Li GL, Jiang Y, Wei JH, Zeng H, Lou YL, Lyu JX, Wan KL. First Report in China on the Identification and Drug Sensitivity of Mycobacterium elephantis Isolated from the Milk of a Cow with Mastitis. Biomed Environ Sci. 2017 Jul;30(7):501-507. doi: 10.3967/bes2017.066. PubMed PMID: 28756809. 10: Shimizu S, Sogabe S, Yanagisako R, Inada A, Yamanaka M, Iha HA, Ohno Y. Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway. Int J Mol Sci. 2017 Jul 3;18(7). pii: E1416. doi: 10.3390/ijms18071416. PubMed PMID: 28671605; PubMed Central PMCID: PMC5535908. 11: Bharkavi C, Vivek Kumar S, Ashraf Ali M, Osman H, Muthusubramanian S, Perumal S. One-pot microwave assisted stereoselective synthesis of novel dihydro-2'H-spiro[indene-2,1'-pyrrolo-[3,4-c]pyrrole]-tetraones and evaluation of their antimycobacterial activity and inhibition of AChE. Bioorg Med Chem Lett. 2017 Jul 15;27(14):3071-3075. doi: 10.1016/j.bmcl.2017.05.050. Epub 2017 May 17. PubMed PMID: 28552337. 12: Shi S, Shen Y, Zhang S, Zhao Z, Hou Z, Zhou H, Zou J, Guo Y. Combinatory Evaluation of Transcriptome and Metabolome Profiles of Low Temperature-induced Resistant Ascites Syndrome in Broiler Chickens. Sci Rep. 2017 May 24;7(1):2389. doi: 10.1038/s41598-017-02492-8. PubMed PMID: 28539642; PubMed Central PMCID: PMC5443777. 13: Pait IGU, Kitani S, Kurniawan YN, Asa M, Iwai T, Ikeda H, Nihira T. Identification and characterization of lbpA, an indigoidine biosynthetic gene in the γ-butyrolactone signaling system of Streptomyces lavendulae FRI-5. J Biosci Bioeng. 2017 Oct;124(4):369-375. doi: 10.1016/j.jbiosc.2017.04.020. Epub 2017 May 20. PubMed PMID: 28533156. 14: Chang MJ, Jin B, Chae JW, Yun HY, Kim ES, Lee YJ, Cho YJ, Yoon HI, Lee CT, Park KU, Song J, Lee JH, Park JS. Population pharmacokinetics of moxifloxacin, cycloserine, p-aminosalicylic acid and kanamycin for the treatment of multi-drug-resistant tuberculosis. Int J Antimicrob Agents. 2017 Jun;49(6):677-687. doi: 10.1016/j.ijantimicag.2017.01.024. Epub 2017 Apr 10. PubMed PMID: 28408267. 15: Vemula H, Ayon NJ, Burton A, Gutheil WG. Antibiotic Effects on Methicillin-Resistant Staphylococcus aureus Cytoplasmic Peptidoglycan Intermediate Levels and Evidence for Potential Metabolite Level Regulatory Loops. Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02253-16. doi: 10.1128/AAC.02253-16. Print 2017 Jun. PubMed PMID: 28320719; PubMed Central PMCID: PMC5444159. 16: Amorim Franco TM, Favrot L, Vergnolle O, Blanchard JS. Mechanism-Based Inhibition of the Mycobacterium tuberculosis Branched-Chain Aminotransferase by d- and l-Cycloserine. ACS Chem Biol. 2017 May 19;12(5):1235-1244. doi: 10.1021/acschembio.7b00142. Epub 2017 Mar 16. PubMed PMID: 28272868; PubMed Central PMCID: PMC5834943. 17: Tassoni R, van der Aart LT, Ubbink M, van Wezel GP, Pannu NS. Structural and functional characterization of the alanine racemase from Streptomyces coelicolor A3(2). Biochem Biophys Res Commun. 2017 Jan 29;483(1):122-128. doi: 10.1016/j.bbrc.2016.12.183. Epub 2016 Dec 29. PubMed PMID: 28042035. 18: Wu YC, Chen CM, Kuo CJ, Lee JJ, Chen PC, Chang YC, Chen TH. Prevalence and molecular characterization of Clostridium difficile isolates from a pig slaughterhouse, pork, and humans in Taiwan. Int J Food Microbiol. 2017 Feb 2;242:37-44. doi: 10.1016/j.ijfoodmicro.2016.11.010. Epub 2016 Nov 12. PubMed PMID: 27870984. 19: Rismondo J, Bender JK, Halbedel S. Suppressor Mutations Linking gpsB with the First Committed Step of Peptidoglycan Biosynthesis in Listeria monocytogenes. J Bacteriol. 2016 Dec 13;199(1). pii: e00393-16. Print 2017 Jan 1. PubMed PMID: 27795316; PubMed Central PMCID: PMC5165104. 20: Bharkavi C, Vivek Kumar S, Ashraf Ali M, Osman H, Muthusubramanian S, Perumal S. A facile stereoselective synthesis of dispiro-indeno pyrrolidine/pyrrolothiazole-thiochroman hybrids and evaluation of their antimycobacterial, anticancer and AchE inhibitory activities. Bioorg Med Chem. 2016 Nov 15;24(22):5873-5883. doi: 10.1016/j.bmc.2016.09.044. Epub 2016 Sep 19. PubMed PMID: 27687968.